Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 25.54B | 25.54B | 24.99B | 27.11B | 23.62B | 22.44B |
Gross Profit | 3.85B | 3.79B | 3.80B | 3.54B | 3.07B | 2.69B |
EBITDA | 2.62B | 2.59B | 2.50B | 3.46B | 1.92B | 1.88B |
Net Income | 746.02M | 746.44M | 796.77M | 1.49B | 523.15M | 542.24M |
Balance Sheet | ||||||
Total Assets | 38.38B | 38.38B | 38.14B | 37.84B | 36.88B | 33.78B |
Cash, Cash Equivalents and Short-Term Investments | 5.27B | 5.27B | 5.61B | 5.03B | 4.11B | 5.01B |
Total Debt | 8.54B | 8.54B | 9.48B | 10.34B | 10.85B | 9.45B |
Total Liabilities | 13.96B | 13.96B | 14.59B | 15.92B | 16.80B | 14.49B |
Stockholders Equity | 21.31B | 21.31B | 20.62B | 19.28B | 17.64B | 17.07B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 966.62M | 1.60B | 1.80B | -2.07B | -1.17B |
Operating Cash Flow | 0.00 | 2.45B | 2.15B | 2.68B | 1.32B | 1.37B |
Investing Cash Flow | 0.00 | -1.18B | -754.05M | -1.65B | -2.13B | -3.91B |
Financing Cash Flow | 0.00 | -1.14B | -1.02B | -948.09M | 1.21B | 1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥10.82B | 14.30 | 1.96% | 3.59% | 3.84% | ||
76 Outperform | ¥13.87B | 14.50 | 2.01% | 15.85% | 16.36% | ||
76 Outperform | ¥16.81B | 18.16 | 1.20% | 2.95% | 6.31% | ||
73 Outperform | ¥5.49B | 6.37 | 2.18% | 0.16% | 100.58% | ||
72 Outperform | ¥60.53B | 20.10 | 1.68% | 13.48% | 34.22% | ||
68 Neutral | ¥27.38B | 16.06 | 2.52% | 4.91% | 1.63% | ||
64 Neutral | $10.73B | 15.74 | 7.60% | 2.01% | 2.75% | -15.09% |